SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
37.21
-0.23 (-0.61%)
Nov 21, 2024, 1:14 PM EST - Market open
SpringWorks Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 135.49 | 5.45 | - | - | 35 | - | Upgrade
|
| Cost of Revenue | 7.42 | 0.42 | - | - | - | - | Upgrade
|
| Gross Profit | 128.07 | 5.03 | - | - | 35 | - | Upgrade
|
| Selling, General & Admin | 239.39 | 197.55 | 134.55 | 71.79 | 29.47 | 16.69 | Upgrade
|
| Research & Development | 183.93 | 150.49 | 146.12 | 101.68 | 51.86 | 42.55 | Upgrade
|
| Operating Expenses | 423.32 | 348.04 | 280.67 | 173.47 | 81.32 | 59.24 | Upgrade
|
| Operating Income | -295.25 | -343.01 | -280.67 | -173.47 | -46.32 | -59.24 | Upgrade
|
| Interest & Investment Income | 26.54 | 22.95 | 6.15 | 0.55 | 1.33 | 3.55 | Upgrade
|
| Earnings From Equity Investments | -6.45 | -5.04 | -2.89 | -0.99 | -0.61 | -2.61 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0.03 | - | Upgrade
|
| Pretax Income | -275.16 | -325.1 | -277.42 | -173.91 | -45.57 | -58.31 | Upgrade
|
| Net Income | -275.16 | -325.1 | -277.42 | -173.91 | -45.57 | -58.31 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | -7.73 | Upgrade
|
| Net Income to Common | -275.16 | -325.1 | -277.42 | -173.91 | -45.57 | -50.58 | Upgrade
|
| Shares Outstanding (Basic) | 72 | 63 | 53 | 48 | 43 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 72 | 63 | 53 | 48 | 43 | 13 | Upgrade
|
| Shares Change (YoY) | 15.26% | 18.45% | 9.88% | 12.00% | 226.18% | 3792.75% | Upgrade
|
| EPS (Basic) | -3.83 | -5.15 | -5.21 | -3.59 | -1.05 | -3.81 | Upgrade
|
| EPS (Diluted) | -3.83 | -5.15 | -5.21 | -3.59 | -1.05 | -3.81 | Upgrade
|
| Free Cash Flow | -209.9 | -230.18 | -171.76 | -129.89 | -32.83 | -48.11 | Upgrade
|
| Free Cash Flow Per Share | -2.92 | -3.65 | -3.22 | -2.68 | -0.76 | -3.62 | Upgrade
|
| Gross Margin | 94.52% | 92.25% | - | - | 100.00% | - | Upgrade
|
| Operating Margin | -217.92% | -6297.28% | - | - | -132.35% | - | Upgrade
|
| Profit Margin | -203.09% | -5968.50% | - | - | -130.21% | - | Upgrade
|
| Free Cash Flow Margin | -154.92% | -4225.81% | - | - | -93.81% | - | Upgrade
|
| EBITDA | -292.26 | -341.35 | -279.91 | -172.98 | -45.98 | -59.05 | Upgrade
|
| EBITDA Margin | -215.71% | - | - | - | -131.36% | - | Upgrade
|
| D&A For EBITDA | 2.99 | 1.67 | 0.77 | 0.49 | 0.35 | 0.19 | Upgrade
|
| EBIT | -295.25 | -343.01 | -280.67 | -173.47 | -46.32 | -59.24 | Upgrade
|
| EBIT Margin | -217.92% | - | - | - | -132.35% | - | Upgrade
|
| Revenue as Reported | 135.49 | 5.45 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.